At 6.4% CAGR, Middle East & Africa Medical Tubing Market is Projected to be Worth US$ 984.17 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa medical tubing market was valued at US$ 600.77 million in 2023 and is expected to reach US$ 984.17 million by 2031, registering a CAGR of 6.4% from 2023 to 2031. Increase in medical applications and expanding applications in biopharmaceutical processing are among the critical factors attributed to drive the Middle East & Africa medical tubing market growth.

Medical tubing is utilized in various medical and pharmaceutical applications, including fluid management, drainage, anesthesiology, respiratory equipment, intravenous (IV) administration, catheters, peristaltic pumps, dialysis, feeding tubes, and biopharmaceutical laboratory equipment. Medical interventions that involve specialized medical tubing are often needed in the management of chronic diseases, such as diabetes, cardiovascular diseases, and cancer. According to the Global Cancer Statistics published in 2022 by GLOBOCAN, the category of trachea, bronchus, and lung cancer was the most common cancer condition worldwide, followed by breast cancer and colorectal cancer, respectively. As per the International Agency for Research on Cancer (IARC), nearly 1 in 5 people would develop cancer during their lifetime, and ~ 1 in 9 men and ~1 in 12 women succumb to the disease. With the rising prevalence of chronic diseases, healthcare systems continuously seek medical devices such as infusion devices, catheters, and IV administration systems using tubing to effectively manage these conditions. Companies such as RAUMEDIC AG and Saint-Gobain offer a wide range of medical tubing systems for drug delivery devices, infusion devices, internal feeding systems, and peristaltic pumps. RAUMEDIC's silicone tubing is ideal for use in medical pump devices. Patients suffering from chronic diseases often require hospitalization, wherein treatment processes such as catheterization, drainage, and infusion involve the use of medical tubing. Patients with serious chronic conditions may also need surgical interventions, making medical tubing products invincible. Reliable and effective medical tubing solutions significantly contribute to patient safety and the success of treatments.

Crohn's disease (a gastrointestinal disease associated with trauma), bowel obstruction, microscopic colitis, short bowel syndrome, and ulcerative colitis are a few of the common gastrointestinal disorders. Patients suffering from these conditions are provided with enteral nutrition, which utilizes feeding tubes, as consuming food orally is not feasible. In September 2023, Cardinal Health launched a novel Kangaroo OMNI enteral feeding pump with a Kangaroo feeding tube featuring IRIS Technology. The pump is equipped with a camera to assist in the placement of small-bore feeding tubes. Developed with a focus on patient safety and innovation, this advanced pump delivers nutrition and hydration for individuals from different age groups, whether in hospitals, at home, or elsewhere. Therefore, an increase in the medical applications of tubing, coupled with a surge in the number of chronic disease cases, drives the medical tubing market toward growth.

On the contrary, recalls due to product failure hamper the growth of Middle East & Africa medical tubing market.

By type, the Middle East & Africa medical tubing market is segmented into polyvinyl Chloride (PVC), polyimide or nylons, PTFE or thermoplastic elastomers (TPES), thermoplastic polyurethanes (TPUS), polyvinylidene fluoride (PVDF), polypropylene and polyethylene, silicone, and others. The polyvinyl Chloride (PVC) segment held 33.0% share of Middle East & Africa medical tubing market share in 2023, amassing US$ 198.01 million. It is projected to garner US$ 323.50 million by 2031 to register 6.3% CAGR during 2023–2031.

In terms of structure, the Middle East & Africa medical tubing market is segmented into single-lumen, multi-lumen, multi-layer extruded tubing, tapered or bump tubing, braided tubing, balloon tubing, corrugated tubing, heat shrink tubing, and others. The single- lumen segment held 19.8% share of Middle East & Africa medical tubing market share in 2023, amassing US$ 118.77 million. It is projected to garner US$ 200.48 million by 2031 to register 6.8% CAGR during 2023–2031.

Based on application, the Middle East & Africa medical tubing market is segmented into bulk disposable tubing, catheters and cannula, drug delivery systems, and others. The bulk disposable tubing segment held 36.3% share of Middle East & Africa medical tubing market share in 2023, amassing US$ 218.17 million. It is projected to garner US$ 360.09 million by 2031 to register 6.5% CAGR during 2023–2031.

By end users, the Middle East & Africa medical tubing market is segmented into hospital and clinics, ambulatory care centers, medical labs, and others. The hospital and clinics segment held 63.4% share of Middle East & Africa medical tubing market share in 2023, amassing US$ 380.66 million. It is projected to garner US$ 618.78 million by 2031 to register 6.3% CAGR during 2023–2031.

Based on country, the Middle East & Africa medical tubing market is categorized into Saudi Arabia, South Africa, the UAE, the Rest of Middle East & Africa. Our regional analysis states that the Rest of Middle East & Africa captured 31.4% share of Middle East & Africa medical tubing market in 2023. It was assessed at US$ 188.40 million in 2023 and is likely to hit US$ 304.27 million by 2031, registering a CAGR of 6.2% during 2023–2031.

Key players operating in the medical tubing market are Air Liquide Medical Systems; Armstrong Medical Ltd; Besmed Health Business Corp; BMC Medical Co Ltd; DeVilbiss Healthcare LLC; Dimar S.P.A.; Dragerwerk AG & Co KGaA; Fisher & Paykel Healthcare Corp Ltd; Hamilton Medical AG; Hangzhou Formed Medical Devices Co., Ltd; Intersurgical Ltd; Koninklijke Philips NV; Medline Industries LP; ResMed Inc; Sleepnet Corporation; SunMed Group Holdings LLC ( AirLife); and SURU INTERNATIONAL PVT. LTD., among others.

• In October 2024: RAUMEDIC extended its portfolio for biopharmaceutical fluid processing products and launched a new brand for biocompatible tubing. Further, the company expanding its global headquarters with a cutting-edge ISO-7 clean room manufacturing facility. Leveraging more than 70 years of polymer processing expertise, the company is offering its state-of-the-art product range directly to the broader market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com